Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05110209
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 331,541
Testing effectiveness (Phase 2)Study completedNCT01345006
What this trial is testing

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Institute for Regenerative Medicine 13
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Testing effectiveness (Phase 2)UnknownNCT01521065
What this trial is testing

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationWet Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 500
Not applicableStudy completedNCT04482465
What this trial is testing

Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD

Who this might be right for
Age-related Macular DegenerationVitamin D Deficiency
Universitaire Ziekenhuizen KU Leuven 50
Large-scale testing (Phase 3)Ended earlyNCT04757636
What this trial is testing

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 998
Large-scale testing (Phase 3)Enrolling By InvitationNCT06951087
What this trial is testing

Intravitreal and Intracameral DEX in NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Affiliated Hospital of Nantong University 80
Not applicableLooking for participantsNCT07085533
What this trial is testing

Natural History Study of Inherited Retinal Diseases

Who this might be right for
Retinal DystrophiesColor Vision DefectsVision Disorders+7 more
Zhongmou Therapeutics 200
Early research (Phase 1)Study completedNCT00407719
What this trial is testing

Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationDegenerative MyopiaPathological Myopia
Johns Hopkins University 10
Not applicableUnknownNCT04907409
What this trial is testing

Home OCT Fluid Visualization Agreement Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 120
Not applicableUnknownNCT04142164
What this trial is testing

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Who this might be right for
Age-related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Prim. Prof. Dr. Oliver Findl, MBA 40
Not applicableStudy completedNCT04756310
What this trial is testing

Study of Nutritional Supplementation in Patients With Unilateral Wet AMD

Who this might be right for
Wet Macular Degeneration
Laboratorios Thea, Spain 109
Early research (Phase 1)Not Yet RecruitingNCT06623279
What this trial is testing

Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
HuidaGene Therapeutics Co., Ltd. 15
Post-approval studies (Phase 4)Study completedNCT01127360
What this trial is testing

LUCAS (Lucentis Compared to Avastin Study)

Who this might be right for
Exudative Age-related Macular Degeneration
Oslo University Hospital 420
Not applicableEnrolling By InvitationNCT04607369
What this trial is testing

Implementation of the NEDS EyeCTester App

Who this might be right for
Optic Nerve DiseaseMacular DiseaseVisual Pathway Disorder
Neuro-Eye Diagnostic Systems, LLC 100
Testing effectiveness (Phase 2)Study completedNCT02507388
What this trial is testing

Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Alcon Research 51
Not applicableStudy completedNCT00991666
What this trial is testing

Association Between Laser Interferometric Measurement of Fundus Pulsation and Pneumotonometric Measurement of Pulsatile Ocular Blood Flow in Patients With Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Medical University of Vienna 100
Not applicableUnknownNCT00627718
What this trial is testing

Assessment of Macular Edema Using HRT Technique

Who this might be right for
Age-Related Macular Degeneration
McGill University Health Centre/Research Institute of the McGill University Health Centre 50
Early research (Phase 1)Study completedNCT02848313
What this trial is testing

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Stealth BioTherapeutics Inc. 40
Next Page